ClinicalTrialsFinder

HER2-low Hormone Receptor Positive Breast Cancer Clinical Trials in Madison, Wisconsin

1 recruitingMadison, Wisconsin

Showing 1–1 of 1 trials

Recruiting
Phase 1Phase 2

Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors

Melanoma (Skin Cancer)HER2-low Hormone Receptor Positive Breast Cancer
Aminex Therapeutics, Inc.92 enrolled8 locationsNCT07287917